Peter Sidaway1. Show Affiliations » 1. Nature Reviews Clinical Oncology, . nrclinonc@nature.com.
Abstract
Entities: Chemical
Mesh: See more » Administration, IntravenousAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/adverse effectsAntineoplastic Agents, Immunological/administration & dosageAntineoplastic Agents, Immunological/adverse effectsB7-H1 Antigen/geneticsClinical Trials, Phase II as TopicFemaleHumansProgrammed Cell Death 1 Receptor/geneticsSurvival AnalysisTreatment OutcomeTriple Negative Breast Neoplasms/drug therapyTriple Negative Breast Neoplasms/genetics
Substances: See more » Antibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanProgrammed Cell Death 1 Receptorpembrolizumab
Year: 2019 PMID: 30573793 DOI: 10.1038/s41571-018-0157-1
Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN: 1759-4774 Impact factor: 66.675